Posterior reversible encephalopathy syndrome associated with blood transfusion in sickle cell anemia: case report
DOI:
https://doi.org/10.11606/issn.1679-9836.v103i5e-226696Keywords:
Posterior Leukoencephalopathy Syndrome, Posterior Reversible Encephalopathy Syndrome, Blood Transfusion, Sickle Cell DiseaseAbstract
Sickle Cell Anemia (SCA) is the most common genetic disease in the world, characterized by frequent vaso-occlusive crises that, along with extensive pathophysiology, predispose individuals to neurological events such as Stroke. Posterior Reversible Encephalopathy Syndrome (PRES), on the other hand, is an uncommon manifestation resulting from vasogenic edema whose pathogenesis is not completely understood. Individuals with hemoglobinopathies have a higher chance of developing PRES; however, there are few reports in the literature on the occurrence of PRES related to SCA. The aim of the study is to report a case in which red blood cell transfusion (RBCT) was followed by PRES in a child with SCA. This is a longitudinal single-arm study with systematic research in major databases using the PICO strategy to associate the three events (SCA, RBC, PRES) with their appropriate medical descriptors. The present study evidenced most findings described in the scientific literature, reinforcing the need to expand knowledge of PRES as a differential diagnosis of neurological events in hemoglobinopathies in order to improve healthcare quality and reduce morbidity and mortality in these individuals
Downloads
References
Bender MA, Carlberg K. Sickle Cell Disease. 2003. In: Adam MP, Feldman J, Mirzaa GM, et al.., editors. GeneReviews [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2024. https://www.ncbi.nlm.nih.gov/books/.
Elendu C, Amaechi DC, Alakwe-Ojimba CE, Elendu TC, Elendu RC, Ayaazu CP, et al. Understanding sickle cell disease: causes, symptoms, and treatment Options. Medicine. 2023;102(38):e35237. Doi: http://dx.doi.org/10.1097/MD.0000000000035237.
Kato GJ, Piel FB, Reid CD, Gaston MH, Ohene-Frempong K, Krishnamurti L, et al. Sickle cell disease. Nat Rev Dis Primers. 2018;18010(4):1-22. Doi: 10.1038/nrdp.2018.10.
Kavanagh PL, Fasipe TA, Wun T. Sickle cell disease: a review. Jama 2022;328(1):57-68. Doi: 10.1001/jama.2022.10233.
Novelli EM, Gladwin MT. Crises in sickle cell disease. Chest. 2016;149(4):1082-93. Doi: http://dx.doi.org/10.1016/j.chest.2015.12.016.
Fugate JE, Rabinstein AA. Posterior reversible encephalopathy syndrome: clinical and radiological manifestations, pathophysiology, and outstanding questions. Lancet Neurol. 2015;14:914-25. Doi: http://dx.doi.org/10.1016/S1474-4422(15)00111-8.
Dube M, Rathore R. Blood-transfusion-related posterior reversible encephalopathy syndrome - a description of a new case and review of the literature. Brain Circulation. 2020;6:269-73. Doi: 10.4103/bc.bc_9_20.
Triplett JD, Kutlubaev MA, Kermode AG, Hardy T. Posterior reversible encephalopathy syndrome (PRES): diagnosis and management. Pract Neurol. 2022;22:183-9. Doi: 10.1136/practneurol-2021-003194.
Hun M, Tian J, Xie M, She Z, Adirahman AS, Han P, et al. Analysis of risk factors associated with poor outcome in posterior reversible encephalopathy syndrome after treatment in children: systematic review and meta-analysis. Front Neurol. 2020;11:938. Doi: 10.1002/pbc.27912.
Solh Z, Taccone MS, Marin S, Athale U, Breakey VR. Neurological PRESentations in sickle cell patients are not always stroke: a review of posterior reversible encephalopathy syndrome in sickle cell disease. Pediatr Blood Cancer. 2016;63:983-9. Doi: 10.1002/pbc.25932.
Khademian Z, Speller-Brown B, Nouraie SM, Minniti CP. Reversible posterior leuko-encephalopathy in children with sickle cell disease. Pediatr Blood Cancer. 2009;52:3735. Doi: 10.1002/pbc.21812.
Singh K, Gupta R, Kamal H, Silvestri NJ, Wolfe GI. Posterior reversible encephalopathy syndrome secondary to blood transfusion. J Clin Neurosc. 2014;22:592-4. Doi: 10.1016/j.jocn.2014.10.005.
Vargas A, Testai FD. Posterior Reversible Encephalopathy Syndrome in adult sickle-cell patients: Case series and literature review. J Clin Neurosc. 2019;70:249-50. Doi: https://doi.org/10.1016/j.jocn.2019.08.070.
Chou ST, Alsawas M, Fasano RM, Field JJ, Hendrickson JE, Howard J, et al. American society of hematology 2020 guidelines for sickle cell disease: Transfusion support. Blood Adv. 2020;4(2):327-55. Doi: https://doi.org/10.1182/BLOODADVANCES.2019001143.
Raj S, Killingger J, Overby P. Blood transfusion in sickle cell disease leading to posterior reversible encephalopathy syndrome (PRES). J Child Neurol. 2012;28(10):1284-6. Doi: 10.1177/0883073812453497.
Regling K, Pomerantz D, Narayanan S, Altinok D, Sivaswamy L, Marapudi NI, et al. Revesible cerebral vasoconstriction syndrome and sickle cell disease: a case report. J Pediatr Hematol Oncol. 2021;43:e95-e98. Doi: 10.1097/MPH.0000000000001683.
Kolovou V, Zampais P, Ginopoulou A, Varvarigou A, Kaleyias J. Reversible posterior leukoencephalopathy syndrome after blood transfusion in a pediatric patient with sickle cell disease. Pediat Neurol. 2013;49:213-7. Doi: http://dx.doi.org/10.1016/j.pediatrneurol.2013.04.024.
Frye RE. Reversible posterior leukoencephalopathy syndrome in sickle cell anemia. Pediatr Neurol. 2009;40(4):298-301. Doi: 10.1016/j.pediatrneurol.2008.10.024.
Alharbi H, Khawar N, Kulpa, Bellin A, Proteasa S, Sndaram R. Neurological complications following blood transfusions in sickle cell anemia. Case Rep Hematol. 2017;2017(1). Doi: http://dx.doi.org/10.1155/2017/3649397.
Thavamani A, Umapathi KK, Puliyel M, Super D, Allareddy V, Ghori A. Epidemiology, comorbidities, and outcomes of posterior reversible encephalopathy syndrome in children in the United States. Pediatr Neurol. 2019;103:21-6. Doi: https://doi.org/10.1016/j.pediatrneurol.2019.07.007.
Zuccoli G, Nardone R, Rajan D, Khan AS, Cummings DD, Nonaneurysmal Subarachnoid Hemorrhage in Sickle Cell Disease. Neurologist. 2018;23:122-7. Doi: 10.1097/NRL.0000000000000181.
Downloads
Published
Issue
Section
License
Copyright (c) 2024 Igor de Assis Franco, Daniela Oliveira Werneck Rodrigues, Isabela Lima dos Santos, Nathalia Noyma Sampaio Magalhães
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
